New Pathology Atlas Launched
Quoting directly: “A new Pathology Atlas has been launched with an analysis of all human genes in [MORE]
Metabolomics
“You have tens of thousands of genes, of which tens of thousands will be expressed – and you also have [MORE]
CRISPR Delivery Mechanism
Getting CRISPR-Cas 9 molecules to their target cells without damage or off-targeting has been an obstacle for gene [MORE]
Cell Types
Recently, researchers called together by the Smithsonian Initiative on Biodiversity Genomics, and the Beijing Genomics Institute, proposed launching a [MORE]
Ewing Sarcoma
A prevailing theory in cancers’ origins is that, over time, cells accumulate enough DNA damage that result in uncontrolled [MORE]
Liquid Biopsy Test
Healthcare ought to have a cohort of people designated as “Uber-wealthy worried well,” or “UWW.” Because, for them, [MORE]
Bio-Rad Illumina Single-Cell Genome Analysis
Early last month, the collaboration between Illumina (San Diego, CA) and Bio-Rad Laboratories (Hercules, CA) released [MORE]
Blood Sample
Liquid biopsy isn’t yet the gold standard for tumor analysis, but it is moving rapidly in that direction. This [MORE]
Health Technology
Now, as we proceed into the era of “big data” healthcare, a recent survey reveals that more than half [MORE]
DNA
About a third of men who are successfully treated (surgery and radiation) for localized prostate cancer still go on to [MORE]
Foundation Medicine (Cambridge, MA) and Guardant Health (Redwood City, CA) both have genomic sequencing platforms for genomic cancer. Foundation analyzes [MORE]
Yoshinori Ohsumi
Last month, Yoshinori Ohsumi won this year’s Nobel Prize for Physiology or Medicine for his discoveries about the cellular [MORE]
RNA Making DNA Copies in a Droplet of Water
In the evolution of life on Earth, reverse transcriptase played a leading [MORE]
Data Entry
As the end of June, the National Cancer Institute announced its partnering with Foundation Medicine, Inc. to expand the [MORE]